P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

M. Abdelrahim; A. Esmail; A. Saharia; S. Kodali; D. Victor; K. Heyne; R. Ghobrial

doi:10.1016/j.annonc.2022.04.251

P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

M. Abdelrahim, A. Esmail, A. Saharia, S. Kodali, D. Victor, K. Heyne, R. Ghobrial

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S307
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.04.251
State	Published - 2022

Divisions

Abdominal Transplant
Gastroenterology and Hepatology
Medical Oncology

Access to Document

10.1016/j.annonc.2022.04.251

https://www.sciencedirect.com/science/article/pii/S0923753422009413

Cite this

Abdelrahim, M., Esmail, A., Saharia, A., Kodali, S., Victor, D., Heyne, K., & Ghobrial, R. (2022). P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology, 33, S307. https://doi.org/10.1016/j.annonc.2022.04.251

P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. / Abdelrahim, M.; Esmail, A.; Saharia, A. et al.
In: Annals of Oncology, Vol. 33, 2022, p. S307.

Research output: Contribution to journal › Article › peer-review

Abdelrahim, M , Esmail, A , Saharia, A , Kodali, S, Victor, D, Heyne, K & Ghobrial, R 2022, 'P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022', Annals of Oncology, vol. 33, pp. S307. https://doi.org/10.1016/j.annonc.2022.04.251

Abdelrahim M , Esmail A , Saharia A , Kodali S, Victor D, Heyne K et al. P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology. 2022;33:S307. doi: 10.1016/j.annonc.2022.04.251

Abdelrahim, M. ; Esmail, A. ; Saharia, A. et al. / P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma : Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. In: Annals of Oncology. 2022 ; Vol. 33. pp. S307.

@article{ff548dafa7c24c7eb2806cae2e67ea1e,

title = "P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022",

author = "M. Abdelrahim and A. Esmail and A. Saharia and S. Kodali and D. Victor and K. Heyne and R. Ghobrial",

year = "2022",

doi = "10.1016/j.annonc.2022.04.251",

language = "English (US)",

volume = "33",

pages = "S307",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma

T2 - Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

AU - Abdelrahim, M.

AU - Esmail, A.

AU - Saharia, A.

AU - Kodali, S.

AU - Victor, D.

AU - Heyne, K.

AU - Ghobrial, R.

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.04.251

DO - 10.1016/j.annonc.2022.04.251

M3 - Article

SN - 0923-7534

VL - 33

SP - S307

JO - Annals of Oncology

JF - Annals of Oncology

ER -